V79-GalK1 Cells
General information
| Description | This cell line is a clonal derivative of V79 cells that had been treated with ethylmethanesulfonate. The cells are deficient in galactokinase and are resistant to 2-deoxygalactose and 8-azaguanine. |
|---|---|
| Organism | Chinese hamster |
| Tissue | Lung |
| Disease | Normal lung fibroblast (galactokinase-deficient; EMS-mutagenized V79 derivative; resistant to 2-deoxygalactose and 8-azaguanine) |
| Metastatic site | Not applicable (Chinese hamster lung fibroblast cell line; not a tumor sample) |
| Applications | Mutation research; genetic toxicology; genotoxicity testing; galactokinase deficiency complementation studies; HPRT-deficient parent V79 genetics; CHO/V79 model comparisons; DNA repair research |
Characteristics
| Gender | Male |
|---|---|
| Ethnicity | Not applicable (Chinese hamster cell line) |
| Morphology | Fibroblast-Like |
| Cell type | Fibroblast |
| Growth properties | Adherent |
Regulatory Data
| Citation | V79-GalK1 (Cytion catalog number 305011) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10029 |
| CellosaurusAccession | CVCL_2797 |
| GMO Status | No genetic modification (mutagenesis by EMS is a chemical mutagen treatment, not stable transgene introduction); carries galactokinase deficiency and 8-azaguanine resistance arising from endogenous mutations |
Biomolecular Data
| Karyotype | 2n=22 |
|---|
Handling
| Culture Medium | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Doubling time | approx. 14 to 18 hours (V79-derived; rapid doubling) |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Split ratio | 1 to 5 |
| Seeding density | 2-4*10^4/cm² |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|